EUCTR2009-016923-77-IT进行中（未招募）不适用
Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism - SURVET study
ALFA WASSERMA0 个研究点目标入组 784 人开始时间: 2010年11月30日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 784
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age =18 years, of both sexes and any ethnical group -Patients treated with anticoagulant therapy (with VKA) for 3-12 months due to a documented previous unprovoked (defined as not triggered by: major/orthopaedic surgery, immobilization due to setting for more than 4 days and due to plaster, major trauma) DVT or PE -Patients who stopped VKA therapy from more than 1 week and less than 3 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Secondary VTE (due to major/orthopaedic surgery, immobilization due to setting for more than 4 days and due to plaster, major trauma) - Current pregnancy or during puerperium (first 6 weeks after birth) at the time of examination for inclusion in the study -Pulmonary embolism associated with shock or life threatening prolonged hypotension or persistence of pulmonary hypertension after pulmonary embolism -Two or more documented episodes of proximal VTE of lower limbs and/or pulmonary embolism -DVT in areas other than lower limbs -Isolated distal DVT (thrombosis of calf)
研究者
相似试验
进行中（未招募）
不适用
Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism - SURVETVenous ThromboembolismMedDRA version: 14.0Level: LLTClassification code 10066899Term: Venous thromboembolismSystem Organ Class: 10047065 - Vascular disordersEUCTR2009-016923-77-PLAlfa Wassermann SpA784
进行中（未招募）
不适用
Multicentre, randomised, double blind, placebo controlled trial of ascorbic acid treatment in Charcot-Marie-Tooth Disease Type 1A CMT1A .EUCTR2004-004501-24-ITISTITUTO NEUROLOGICO CARLO BESTA200
进行中（未招募）
1 期
Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism. - SURVET studyEUCTR2009-016923-77-PTALFA WASSERMANN SPA617
进行中（未招募）
不适用
Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism - SURVETMedDRA version: 12.1Level: LLTClassification code 10066899Term: Venous thromboembolismVenous ThromboembolismEUCTR2009-016923-77-CZAlfa Wassermann SpA784
进行中（未招募）
1 期
Multicentre, randomised, double blind, placebo controlled study on long-term treatment with Sulodexide for prevention of recurrent DVT in patients with venous thromboembolism - SURVETMedDRA version: 12.1Level: LLTClassification code 10066899Term: Venous thromboembolismVenous ThromboembolismEUCTR2009-016923-77-SKAlfa Wassermann SpA784